Webinars
"Cardiac troponin in suspected myocardial infarction
Dr. Neumann from the UKE in Hamburg will contribute an interesting scientific webinar on the topic of troponin diagnostics. The UKE in Hamburg evaluated PATHFAST™ for the 0/1 hour algorithm in the past which led to the listing of PATHFAST™ in the ESC Guidelines. In this webinar, Dr. Neumann shares his experience with PATHFAST™ and discusses other exciting topics such as the relevance of acute myocardial infarction (AMI) today, the role of high-sensitivity troponin today, and new diagnostic concepts. Learn about Emergency biomarkers, Workflow and clinical algorithms in the ED and the Advantages of using biomarkers.
“How to improve clinical practice using sepsis biomarkers”
Prof. Evangelos J. Giamarellos-Bourboulis . Sepsis diagnosis and prognosis is still a big challenge for laboratory medicine. In this webinar Prof. Evangelos J. Giamarellos-Bourboulis, will discuss about the use of sepsis biomarkers and how they can improve our clinical practice.
"Optimal use of hsTnI in the ED: advantages and barriers”
Prof. John Parissis from University Clinic of Emergency Medicine in Athens, Greece . Measurement of cardiac troponin is an important component for the rapid and appropriate diagnosis of AMI patients in the often very frequented emergency departments. Learn about the contemporary use of troponin, the common algorithms, the advantages but also the limitations of troponin diagnostics in the emergency department.
“How to improve clinical practice using sepsis biomarkers”
Prof. Evangelos J. Giamarellos-Bourboulis . Sepsis diagnosis and prognosis is still a big challenge for laboratory medicine. In this webinar Prof. Evangelos J. Giamarellos-Bourboulis, will discuss about the use of sepsis biomarkers and how they can improve our clinical practice.
"PCT and Presepsin, opponents or complementary biomarkers in laboratory medicine practice?"
Prof. Plebani. Within the frame of this presentation Prof. Plebani will give a recent overview of the current clinical application of presepsin and PCT and show latest studies, discussing the common biomarker approach in routine clinical diagnostics from a scientific perspective.